Search Results - "Bardaji, M.J. Lostes"

50P Transcriptomic profiles of CD32b in breast cancer predict outcome and are associated with immune activation by Rojas Laimito, K.I., Vieito Villar, M., Galvao de Aguiar, V., Saavedra Santa Gadea, O., Lostes Bardaji, M.J., Oberoi, A., Alonso, G., Brana, I., Tabernero, J., Garralda, E.

Get full text

933P Real-world patterns of immunotherapy utilization and outcomes in recurrent/metastatic head and neck cancer (R/M HNC) patients across European countries: A multicenter retrospective federated analysis by Plavc, G., Calisto, R.S., Paratore, C., Lostes Bardaji, M.J., Hallan Naderi, E., Rutkowski, T., Kovac, A., Cortez, A., Pretelli, G., Braña, I., Vieira, C., Bento, M.J., Kolenc Mokotar, K., Di Maio, M., Sperone, P., Vignani, F.

Get full text

294P Adult population with BRAF-mutated (BRAFmut) and NF1-mutated (NF1mut) gliomas. Analysis of the potential role of targeted therapy (TT) in these patients (pts) by Lostes Bardaji, M.J., Rezqallah Aron, M.A., Gonzalez Rodriguez, M., Villacampa Javierre, G., Martinez Saez, E., Auger, C., Maldonado, X., Martinez Ricarte, F., Tabernero, J., Carles Galceran, J., Garralda, E., Vieito Villar, M.

Get full text

538P Single-center retrospective analysis of patients with brain metastases included in early phase clinical trials by Pretelli, G., Laimito, K.I. Rojas, Alonso, G., Bardaji, M.J. Lostes, Calvo, A. Hernando, Galvao, V., Oberoi, A., Morillo, B. Ortega, Santa Gadea, O. Saavedra, Moya, J. Ginard, Manich, C. Saura, Fernandez, M.E. Elez, Ortiz, C., Couselo, E. Muñoz, Braña, I., Perez, A. Callejo, Galceran, J. Carles, Felip, E., Garralda, E., Villar, M. Vieito

Get full text

702P Characterization of germline HLA genotypes in patients (pts) with solid tumors treated with immunotherapy by Rojas Laimito, K.I., Vieito Villar, M., Moya Hernández, M.Á., Pretelli, G., Lostes Bardaji, M.J., Saavedra Santa Gadea, O., Hernando Calvo, A., Galvao, V., Oberoi, A., Alonso, G., Braña, I., Ginard Moya, J., Baraibar Argota, I., Saura Manich, C., Muñoz Couselo, E., Macarulla, T., Garcia Duran, C., Carles Galceran, J., Tabernero, J., Garralda, E.

Get full text

1080TiP An investigator-initiated phase I study to assess the safety and tolerability of ex vivo next-generation neoantigen-selected tumor-infiltrating lymphocyte (TIL) therapy in advanced immune checkpoint blockade (ICB) resistant solid tumors (NEXTGENTIL-ACT) by Galvao, V., Palomero, J., Creus-Gonzalez, I., Lostes Bardaji, M.J., Lozano-Rabella, M., Garcia-Garijo, A., Yuste, A., Rodriguez, L., Villalobos Alberú, X., Rotxes, M., Vieito Villar, M., Saavedra Santa Gadea, O., Alonso, G., Braña, I., Muñoz-Couselo, E., Querol, S., Tabernero, J., Martín-Lluesma, S., Gros, A., Garralda, E.

Get full text

702P Genomic alterations in epigenetic modifiers and response to epigenetic-targeted agents (ETAs) in patients (pts) with recurrent/metastatic (R/M) salivary gland tumours (SGTs) by Rezqallah Aron, M.A., Hernando-Calvo, A., Galvao de Aguiar, V., Saavedra Santa Gadea, O., Assaf Pastrana, J.D., Lostes Bardaji, M.J., Rojas Laimito, K.I., Aguilar Izquierdo, S., Berché, R., Tian, T., Bescós, C., Lorente, J., Giralt, J., Temprana-Salvador, J., Alberola, M., Dienstmann, R., Felip, E., Garralda, E., Vieito Villar, M., Brana, I.

Get full text

729MO Final results of the first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in combination with nivolumab in subjects with solid tumors relapsed/refractory to prior anti-PD1/PD-L1 treatment by Melero, I., De Miguel, M.J., Alonso Casal, G., Goebeler, M-E., Ramelyte, E., Calvo, E., Garralda, E., Dummer, R., Rodríguez-Ruiz, M.E., Sayehli, C.M., Sanmamed, M.F., Ramón, J.L., Lostes Bardaji, M.J., Gromke, T., Schuler, M.H.H., Fettes, P., Klar, K., Schuberth-Wagner, C., Wischhusen, J., Leo, E.

Get full text

374P Temozolamide (TMZ) rechallenge at standard or metronomic dose versus other treatments in patients (pts) with high grade glioma with TMZ free-interval (TFI) longer than 3 months (mo) by Garcia-Alvarez, A., Saoudi, N., Gonzalez, M., Ruiz-Pace, F., Saez, E. Martinez, Bardaji, M.J. Lostes, Pastrana, J.D.D. Assaf, Martinez-Ricarte, F., Maldonado, X., Dienstmann, R., Carles, J., Villar, M. Vieito

Get full text

1729P Influence of recent administration and type of oncological treatment (T) in survival of oncological patients (p) with COVID-19: Experience of Vall d’Hebron University Hospital by García-Illescas, D., Saoudi Gonzalez, N., Mirallas, O., Aguilar-Company, J., Ruiz-Camps, I., Garcia-Alvarez, A., Lostes Bardaji, M.J., Valdivia, A., Marmolejo Castaneda, D.H., Rezqallah Aron, M.A., López Valbuena, D.E., Felip, E., Carles, J., Tabernero, J.

Get full text

1807P Real world data on 442 patients (p) with small cell lung cancer (SCLC) treated in the last ten years at Vall d’Hebron Hospital by Saoudi Gonzalez, N., Navarro, A., Villacampa Javierre, G., Garcia-Alvarez, A., Assaf Pastrana, J.D.D., Iranzo, P., Callejo, A., Lostes Bardaji, M.J., Pardo, N., Cedres, S., Martinez-Marti, A., Dienstmann, R., Felip, E.

Get full text

1623P Phase I clinical trials (CT) forge on despite COVID-19 by Bardaji, M.J. Lostes, Aliende, E., Moreno, M., Oberoi, H.K., Braña, I., Saavedra, O., Villar, M. Vieito, Alonso, G., Galvao, V., Carballo, N., Beltran, M., Rovira, P., Cidoncha, I., Manich, C. Saura, Mercade, T. Macarulla, Oaknin, A., Galceran, J. Carles, Felip, E., Garralda, E., Pujol, S. Perez

Get full text

Impact of timing and technique of gastrostomy placement on the outcome of patients (pts) with head and neck cancer (HNC) by Lostes Bardaji, M.J., Diaz, N.M., Hernando, A., Puiggrós, C., Vilacampa, G., Assaf, J.D., Saudi, N., Ros, J., Garcia, A., Bescós-Atin, C., Lorente, J., Giralt, J., Viaplana, C., Biosca, M., Tabernero, J., Felip, E., Dienstmann, R., Brana, I.

Get full text

1779P - Impact of timing and technique of gastrostomy placement on the outcome of patients (pts) with head and neck cancer (HNC) by Lostes Bardaji, M.J., Diaz, N.M., Hernando, A., Puiggrós, C., Vilacampa, G., Assaf, J.D., Saudi, N., Ros, J., Garcia, A., Bescós-Atin, C., Lorente, J., Giralt, J., Viaplana, C., Biosca, M., Tabernero, J., Felip, E., Dienstmann, R., Brana, I.

“…Nutritional status affects survival of pts with HNC. Close to half HNC pts require enteral nutrition, with percutaneous endoscopic gastrostomy (PEG) being the…”
Get full text

77P Impact of germline HLA genotypes on clinical outcomes in patients (pts) with solid tumors treated with immunotherapy by Vieito Villar, M., Rojas Laimito, K.I., López, D., Berché, R., Saavedra Santa Gadea, O., Alonso Casal, G., Galvao de Aguiar, V., Lostes Bardaji, M.J., Braña, I., Tabernero, J., Garralda Cabanas, E.

Get full text

196TiP A phase I study of REGN6569, a GITR monoclonal antibody (mAb), in combination with cemiplimab in patients with advanced solid tumour malignancies by Lakhani, N., Hamid, O., Braña, I., Reguera Puertas, P., Lopez Criado, M.P., Swiecicki, P.L., De Miguel Luken, M.J., Gil Martín, M., Khong, H., Moreno Garcia, V., Lostes Bardaji, M.J., Sun, F., Sandigursky, S., Zambrano, M., Cristea, M., Fury, M.

Get full text

29O Clinical characterization of long-term survivors in phase I clinical trials by Mirallas, O., Rossi, A., Fernández, E.M., Garcia-Galea, E., Cano, K.S. Vega, Moya, J. Ginard, Calvo, A. Hernando, Pretelli, G., Bardaji, M.J. Lostes, Oberoi, A., Galvao, V., Laimito, K.I. Rojas, Morillo, B. Ortega, Casal, G. Alonso, Izquierdo, S. Aguilar, Braña, I., Dienstmann, R., Villar, M. Vieito, Garralda, E.

Get full text

99P Molecular correlates and treatment outcomes of patients with brain metastasis included in early phase trials: A single-center retrospective analysis by Pretelli, G., Laimito, K.I. Rojas, Casal, G. Alonso, Bardaji, M.J. Lostes, Calvo, A. Hernando, Galvao, V., Oberoi, A., Morillo, B. Ortega, Mirallas, O., Santa Gadea, O. Saavedra, Manich, C. Saura, Fernandez, M.E. Elez, Ortiz, C., Couselo, E. Muñoz, Braña, I., Galceran, J.C., Felip, E., Garralda, E., Villar, M. Vieito

Get full text

93P Evolving landscape of targeted therapies (TT) in early phase clinical trials (EPCT): The RESISTANCE project (360R) by Rossi, A., Braña, I., Villar, M. Vieito, Casal, G. Alonso, Santa Gadea, O. Saavedra, Mirallas, O., Bardaji, M.J. Lostes, Galvao, V., Laimito, K.I. Rojas, Oberoi, A., Pretelli, G., Morillo, B. Ortega, Sanz, M., Izquierdo, S. Aguilar, Raskina, K., Dienstmann, R., Vivancos, A., Tabernero, J., Garralda, E., Calvo, A. Hernando

Get full text

51P Toxicity profile in early clinical trials with fibroblast growth factor receptor (FGFR) inhibitors (FGFRi): 10-years experience of a drug development unit by Rojas Laimito, K.I., Vieito Villar, M., Fullana Grimalt, B., Berché, R., Hierro Carbo, C., Saavedra Santa Gadea, O., Braña, I., Alonso Casal, G., Galvao de Aguiar, V., Lostes Bardaji, M.J., Oliveira, M., Verdaguer, H., Morales Barrera, R., Garcia Duran, C., Zamora, E., Carles Galceran, J., Macarulla, T., Tabernero, J., Garralda Cabanas, E.

Get full text